BIOMESTATINE

This brand name is authorized in Nigeria.

Active ingredients

The drug BIOMESTATINE contains one active pharmaceutical ingredient (API):

1
UNII BDF1O1C72E - NYSTATIN
 

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

 
Read more about Nystatin

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-8889 Pessary Biomestatine 100,000 IU Tablet SUPP 100,000 IU 1 x 15’s (with applicator) Vaginal tablet 28/01/2021
B4-2607 Tablet Biomestatine Tablets TAB 500,000 IU Each tablet contains: Nystatin BP 500,000 IU 28/09/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A07AA02 Nystatin A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-8889, B4-2607

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.